Company intelligence / Profile preview

Normon

Tres Cantos, Madrid, Spain

Ownership: Private
Employees: ~3000
Development stage: Other

Overview

Normon is a leading Spanish generic pharmaceutical company active for over 85 years, offering over 175-180 molecules across retail, hospital, and dental markets. It operates one of the largest and most modern manufacturing complexes in Europe, exporting to more than 90 countries and supplying a broad portfolio that includes small molecule generics, injectables, antibiotics (penicillanic and cephalosporanic), cytotoxics, anesthetics, and dental biomaterials. No current clinical-stage novel therapeutics are reported, as core business is mature, commercialized products[1][5][6][7][3].

Modalities: Small moleculeBiologicProteinPeptides
Industry: Biotech

Beyond the preview

Go deeper on Normon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Normon.

Explore the full profile